Search

Abdulkareem M Albekairy,1– 3 Mohammad S Shawaqfeh,1,2 Shroug H Alharbi,3,4 Faisal Almuqbil,1,2 Mesfer A Alghamdi,3,5 Nataleen A Albekairy,6 Suhaib M Muflih,7 Abdulmalik Alkatheri1– 3 1Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 2King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; 3Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia; 4King Faisal Specialist Hospital and Research center, Jeddah, Saudi Arabia; 5Clinical Pharmacy Department, King Saud Medical City, Riyadh, Saudi Arabia; 6College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 7Department of Clinical Pharmacy, College of Pharmacy, Jordan University of Science and Technology, Irbid, JordanCorrespondence: Abdulkareem M Albekairy, Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, Tel +966 11-4295001, Email bekairy@gmail.com; bekairya@ngha.med.saIntroduction: Cytomegalovirus infection is one of the opportunistic infections that occur within the first year of solid organ transplantation (SOT). Antiviral prophylaxis like valganciclovir is recommended for organ transplant recipients if the donors are seropositive. The study aims to assess the association between compliance with CMV prevention guidelines and the incidence of CMV infection post kidney and liver transplantation.Methods: A single-center, cross-sectional chart review study was conducted at a tertiary care facility. The study included patients with liver and/or kidney transplantation and received valganciclovir for CMV prevention. The primary endpoint is to determine the incidence of CMV post SOT. The secondary endpoint is to assess the association between compliance with the CMV prevention guidelines and the incidence of CMV infection. Descriptive statistics were used to report the inciden

Reema Karasneh,1 Abdel-Hameed Al-Mistarehi,2 Sayer Al-Azzam,3 Sawsan Abuhammad,4 Suhaib M Muflih,3 Sahar Hawamdeh,3 Karem H Alzoubi3,5 1Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan; 2Department of Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan; 3Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 4Department of Maternal and Child Health, Jordan University of Science and Technology, Irbid, 22110, Jordan; 5Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab EmiratesCorrespondence: Reema KarasnehDepartment of Basic Medical Science, Faculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, JordanTel +962 2 7211111 Ext 7141Fax +962 2 7211162Email reema.karasneh@yu.edu.joBackground: The protection of patient confidentiality is an essential practice for the successful provision of healthcare. This study examines physicians’ knowledge and attitudes related to data sharing and patient confidentiality.Methods: This is a descriptive, questionnaire-based study. Physicians were invited via e-mail to complete the study survey. The survey comprised three sections related to knowledge, attitudes, and demographic characteristics.Results: A total of 221 physicians, with varying levels of experience and from a range of specialty areas, completed the study survey. Ethical dilemmas were encountered annually by physicians specialized in family medicine and daily by physicians in internal medicine wards more often than those in other departments. The mean score for knowledge was 7.34 (out of 14; SD=2.92) and had a positive correlation with attitudes towards the protection of data confidentiality (r2=0.282, p< 0.001). Undergraduate courses were the main source of knowledge related to ethical issues (167; 74.9%). Sex (B=-1.47, p=0.001), ma

Reema A Karasneh,1 Sayer I Al-Azzam,2 Karem H Alzoubi,2 Sahar S Hawamdeh,2 Suhaib M Muflih2 1Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan; 2Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JordanCorrespondence: Reema A KarasnehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, P.O. Box 566, Irbid 21163, JordanTel +962 02 7211111, Ext: 7141Fax +962 02 7211162Email reema.karasneh@yu.edu.joPurpose: The main focus of this study is to assess the knowledge and practices of healthcare practitioners regarding data sharing, security, and confidentiality, with a focus on the use of health data retrieved from electronic health records (EHRs) for research purposes.Methods: A descriptive, cross-sectional, questionnaire-based survey study was conducted across all academic institutions including all researchers in the medical field in Jordan. Personal and administrative practices in data sharing were assessed through collecting data from respondents.Results: The response rate was 22% with an average of 10.25 years of experience in publications. Almost 60% had published at least 1 to 3 studies using EHRs. The prevalence of researchers who “Always” used antivirus software and preserved patient’s information was 75.5% and 92.2%, respectively. However, other personal security and confidentiality measures were not satisfactory. Less than half of health data used in the research was “Always” anonymised or encrypted and only around 44.0% had “Always” used sensitive data with more specificity than normal data.Conclusion: Confidentiality and data sharing practices of healthcare practitioners and researchers were generally less than optimal. Efforts from healthcare providers, health institutions, and lawmakers should be put in place to protect the security and confidentiality of electronic p